首页> 外文期刊>Transfusion and apheresis science: official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis >Advances in transfusion science for shock-trauma: Optimising the clinical management of acute haemorrhage
【24h】

Advances in transfusion science for shock-trauma: Optimising the clinical management of acute haemorrhage

机译:休克创伤输血科学进展:优化急性出血的临床管理

获取原文
获取原文并翻译 | 示例
       

摘要

The primary resuscitation of severely injured patients, acute haemorrhage and shock-trauma has been well reported in the literature. Resuscitation protocols include the use of diverse agents such as fresh whole blood [FWB], packed red blood cells [PRBCs], reconstituted blood products, fresh frozen plasma [FFP] and its derivative concentrates or recombinant products, volume expanders and tranexamic acid [TXA]. The reasonably prudent use of these agents and products is necessary to reverse risk factors of haemorrhagic shock such as haemodilution, hypothermia, acidosis and coagulopathy. Addressing the mechanisms of haemoregulation in the pathophysiology of DIC is important to optimise transfusion practice. (C) 2015 Published by Elsevier Ltd.
机译:文献中已广泛报道了重伤患者,急性出血和休克性创伤的初次复苏。复苏方案包括使用多种药物,例如新鲜全血[FWB],包装的红细胞[PRBC],重建的血液产品,新鲜冷冻血浆[FFP]及其衍生物浓缩物或重组产品,扩容剂和氨甲环酸[TXA] ]。合理谨慎使用这些药物和产品对于逆转出血性休克的危险因素(如血液稀释,体温过低,酸中毒和凝血病)是必要的。解决DIC病理生理学中的血液调节机制对于优化输血实践很重要。 (C)2015由Elsevier Ltd.出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号